Capital Performance Advisors’s Bio-Techne TECH Stock Holding History

Capital Performance Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-35	Closed	-$2.8K	–	2419
2024 Q3	$2.8K	Buy	+35	New	+$2.63K	﹤0.01%	1394

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Capital Performance Advisors's TECH Position: Q4 2024 in Review

Capital Performance Advisors sold out of Bio-Techne (TECH) in Q4 2024, closing a stake of 35 shares — an estimated $2.8K sold.

Capital Performance Advisors first reported a position in TECH in Q3 2024 and held it in 1 quarter. The position peaked at $2.8K in Q3 2024. 576 funds tracked by Wall St. Rank hold TECH as of Q4 2024.

Capital Performance Advisors reported no remaining Bio-Techne position as of Q4 2024 after selling out during the quarter.
Capital Performance Advisors sold 35 Bio-Techne shares in Q4 2024, an estimated $2.8K.
Capital Performance Advisors first reported a position in Bio-Techne in Q3 2024 and held it in 1 quarter.
Capital Performance Advisors's Bio-Techne position peaked at $2.8K in Q3 2024.
576 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.